Safety Study of MGAH22 in HER2-positive Carcinomas

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by MacroGenics
Sponsor:
Collaborators:
Green Cross Corporation
Information provided by (Responsible Party):
MacroGenics
ClinicalTrials.gov Identifier:
NCT01148849
First received: June 17, 2010
Last updated: November 10, 2014
Last verified: November 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: March 2016 (Final data collection date for primary outcome measure)